FRACTALBSEFractal Analytics Ltd· IT - SoftwareHighNeutral
Announced Mon, 11 May, 2026 · 22:53 IST

Press Release on the Audited Consolidated and Standalone Financial Results for the quarter and year ended March 31, 2026

Pat Growth 25pctEbitda Margin ExpansionResults View source PDFExplain this filing

FRACTAL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-2.8%Reaction day
₹1064.65
prior close
₹1099.70
announcement price
After-mkt
timing
Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)-3.0%+0.2% vs market
Computers - Software & Consulting peers, median of 67sector-3.3%+0.5% vs sector

On the reaction day the stock moved 0.2 pts more than Nifty Smallcap 250 and 0.5 pts more than its Computers - Software & Consulting peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-3.9
10m
-4.2
15m
-3.9
30m
-2.6
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-2.8-3.0+0.2-3.3+0.5
Next day
-11.8-2.7-9.1-3.8-8.0
2d
-11.8-2.7-9.1-4.1-7.7
3d
-11.5-3.1-8.4-4.7-6.8
4d
-12.8-4.5-8.3-4.1-8.8
5d
-11.7-3.4-8.3-1.7-10.0
1w
-14.2-2.6-11.6-2.9-11.4
15d
-5.3-1.7-3.6-2.5-2.8
1m
-10.9-1.0-9.8-5.9-4.9
2m
-20.3+5.3-25.6-0.9-19.3
3m
-22.5+6.3-28.8-3.3-19.2
UpDownMarket · Nifty Smallcap 250Sector · Computers - Software & Consulting peers, median of 67Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Fractal Analytics reported strong Q4 FY26 results with revenue of Rs 886 crore, up 17% YoY, and net income of Rs 116 crore, up 109% YoY. Gross margin expanded to 48.2% and adjusted EBITDA margin reached 22%. For the full year FY26, revenue grew 19% to Rs 3,300 crore while net income rose 30% to Rs 287 crore. Healthcare and Life Sciences led growth at 66% YoY, followed by BFSI at 32%. Europe revenues grew 34% and Americas grew 20%. The company expanded its client base with $20 million plus clients increasing from 5 to 6, and $1 million plus clients growing from 53 to 59. Net Income margin expanded by 72 bps to 8.7%.

Likely market impact

The company delivered robust profit growth with strong margin expansion across all key metrics, indicating operational efficiency improvements. The strong 112% Net Revenue Retention signals continued client stickiness and upsell potential. The stock appears to be in a solid growth trajectory with diversified segment performance.